Filtros : "Mangone, Flavia R" Limpar

Filtros



Refine with date range


  • Source: Breast cancer management. Unidade: FM

    Subjects: NEOPLASIAS MAMÁRIAS, EXPRESSÃO GÊNICA, IMUNOHISTOQUÍMICA, PROTEÍNAS DO TECIDO CONJUNTIVO

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALCANTARA FILHO, Paulo R. de et al. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC). Breast cancer management, v. 7, n. 2, 2018Tradução . . Disponível em: https://doi.org/10.2217/bmt-2017-0019. Acesso em: 06 jun. 2024.
    • APA

      Alcantara Filho, P. R. de, Mangone, F. R., Pavanelli, A. C., Garcia, S. A. de B., Nonogaki, S., Andrade, V. P. D., & Nagai, M. A. (2018). Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC). Breast cancer management, 7( 2). doi:10.2217/bmt-2017-0019
    • NLM

      Alcantara Filho PR de, Mangone FR, Pavanelli AC, Garcia SA de B, Nonogaki S, Andrade VPD, Nagai MA. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) [Internet]. Breast cancer management. 2018 ; 7( 2):[citado 2024 jun. 06 ] Available from: https://doi.org/10.2217/bmt-2017-0019
    • Vancouver

      Alcantara Filho PR de, Mangone FR, Pavanelli AC, Garcia SA de B, Nonogaki S, Andrade VPD, Nagai MA. Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC) [Internet]. Breast cancer management. 2018 ; 7( 2):[citado 2024 jun. 06 ] Available from: https://doi.org/10.2217/bmt-2017-0019
  • Source: Clinics. Unidade: FM

    Subjects: PROGNÓSTICO, NEOPLASIAS MAMÁRIAS, MUTAÇÃO GENÉTICA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MANGONE, Flavia R et al. PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients. Clinics, v. 67, n. 11, p. 1285-1290, 2012Tradução . . Disponível em: https://doi.org/10.6061/clinics/2012(11)11. Acesso em: 06 jun. 2024.
    • APA

      Mangone, F. R., Bobrovnitchaia, I. G., Salaorni, S., Manuli, E., & Nagai, M. A. (2012). PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients. Clinics, 67( 11), 1285-1290. doi:10.6061/clinics/2012(11)11
    • NLM

      Mangone FR, Bobrovnitchaia IG, Salaorni S, Manuli E, Nagai MA. PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients [Internet]. Clinics. 2012 ; 67( 11): 1285-1290.[citado 2024 jun. 06 ] Available from: https://doi.org/10.6061/clinics/2012(11)11
    • Vancouver

      Mangone FR, Bobrovnitchaia IG, Salaorni S, Manuli E, Nagai MA. PIK3CA exon 20 mutations are associated with poor prognosis in breast cancer patients [Internet]. Clinics. 2012 ; 67( 11): 1285-1290.[citado 2024 jun. 06 ] Available from: https://doi.org/10.6061/clinics/2012(11)11

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024